Moxifloxacin (Avelox); ciprofloxacin (Cipro), both standard and extended release; gemifloxacin
(Factive); levofloxacin (Levaquin); and ofloxacin are the fluoroquinolones currently approved by the FDA for systemic use.
Their active ingredients are moxifloxacin, ciprofloxacin, gemifloxacin
, levofloxacin, and ofloxacin, respectively.
In research by Syed Qaiser Shah * Muhammad Rafiullah Khan was released in December 2010 , the composition of, Gemifloxacin
- technetium- 99 , introduced as a special agent for imaging of infections caused by Streptococcus pneumonia.
Summary: A sequential injection analysis (SIA) with chemiluminescence detection has been proposed for the determination of the antibiotic gemifloxacin
The updated warnings apply to all approved fluoroquinolones: levofloxacin (Levaquin), ciprofloxacin (Cipro), moxifloxacin (Avelox), norfloxacin (Noroxin), ofloxacin (Floxin), and gemifloxacin
The two regimens were injectable gentamicin in combination with oral azithromycin and oral gemifloxacin
in combination with oral azithromycin.
Gastrointestinal adverse effects occurred in 47% of the patients who received gentamicin plus azithromycin and in 55% of those who got gemifloxacin
The fluoroquinolone drugs that will carry the new labeling include ciprofloxacin (marketed as Cipro and generic ciprofloxacin), ciprofloxacin extended release (Cipro XR and proQuin XR), gemifloxacin
(Factive), levofloxacin (Levaquin), moxifloxacin (Avelox), norfloxacin (Noroxin), and ofloxacin (Floxin and generic ofloxacin).
Examples are azithromycin, clarithromycin, erythromycin, doxycycline, gemifloxacin
, levofloxacin, and moxifloxacin, but each drug has specific benefits and limitations, so don't take any of them without your doctor's prescription.
8% of patients receiving gemifloxacin
and was more commonly observed in patients less than 40 years of age, especially females.
Briefly, 1,325-bp fragments of gyrA and 778 bp of parC were amplified by polymerase chain reaction from 2 previously characterized (18) clinical isolates of QRSP (CT01147 and UABI69; gemifloxacin
MIC = 1 [micro]g/mL) by using the primers shown in the Table.
Group B contains agents (clindamycin, gatifloxacin, levofloxacin, moxifloxacin, sparfloxacin, gemifloxacin
, ofloxacin, tetracycline, and vancomycin) that warrant testing but can be reported selectively based on decisions made at your institution.